These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3708607)

  • 1. Antiemetic studies: a methodological discussion.
    Olver IN; Simon RM; Aisner J
    Cancer Treat Rep; 1986 May; 70(5):555-63. PubMed ID: 3708607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiemetic study design: desirable objectives, stratifications and analyses.
    Olver IN
    Br J Cancer Suppl; 1992 Dec; 19():S30-3; discussion S33-4. PubMed ID: 1467198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems in antiemetic trial design and interpretation.
    Krasnow SH
    Oncology (Williston Park); 1989 Aug; 3(8 Suppl):5-10. PubMed ID: 2701576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Special feature: in quest of an effective antiemetic in cancer chemotherapy. Research with antiemetics for cancer chemotherapy: problems and possibilities.
    Maxwell MB
    Oncol Nurs Forum; 1982; 9(3):11-6. PubMed ID: 7050931
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nurses' perceptions of antiemetic effectiveness.
    Rhodes VA; McDaniel RW; Simms SG; Johnson M
    Oncol Nurs Forum; 1995 Sep; 22(8):1243-52. PubMed ID: 8532549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination].
    Harousseau JL; Zittoun R; Bonneterre J; Hedouin M; Ouvry J
    Bull Cancer; 2000 Jun; 87(6):491-7. PubMed ID: 10903790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Employment of substandard antiemetic prophylaxis in recent trials of chemotherapy-induced nausea and vomiting.
    Holdsworth MT; Vo-Nguyen T
    Ann Pharmacother; 2005 Nov; 39(11):1903-10. PubMed ID: 16204394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodology in anti-emetic trials.
    Olver IN
    Oncology; 1992; 49(4):269-72. PubMed ID: 1522983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
    Padrón F; Sanz J; Flórez J
    Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
    [No Abstract]   [Full Text] [Related]  

  • 14. Issues in the measurement of nausea.
    Del Favero A; Tonato M; Roila F
    Br J Cancer Suppl; 1992 Dec; 19():S69-71. PubMed ID: 1467206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General statistical design considerations of randomized clinical trials.
    Peduzzi P
    Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
    Mehta NH; Reed CM; Kuhlman C; Weinstein HJ; Parsons SK
    Oncol Nurs Forum; 1997 Oct; 24(9):1539-44. PubMed ID: 9348595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological issues in infertility research.
    Daya S
    Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):779-97. PubMed ID: 17118261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
    Herrstedt J
    Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
    Colls BM; Ferry DG; Gray AJ; Harvey VJ; McQueen EG
    N Z Med J; 1980 Jun; 91(662):449-51. PubMed ID: 6250106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.